CHRRX | VSTSX | CHRRX / VSTSX | |
Total Expense Ratio | 1.26 | 0.01 | 12,600% |
Annual Report Gross Expense Ratio | 1.26 | 0.01 | 12,600% |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 9.892 | 9.324 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.61B | 1.91T | 0% |
Annual Yield % from dividends | 0.25 | 1.20 | 21% |
Returns for 1 year | 9.57 | 16.03 | 60% |
Returns for 3 years | 31.08 | 50.01 | 62% |
Returns for 5 years | 32.67 | 85.70 | 38% |
Returns for 10 years | 10.82 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
STCZX | 17.65 | 0.01 | +0.06% |
Virtus Silvant Large-Cap Growth Stk R6 | |||
INUTX | 39.92 | 0.01 | +0.03% |
Columbia Dividend Opportunity A | |||
CLREX | 55.49 | -0.05 | -0.09% |
Columbia Balanced Inst2 | |||
IEQAX | 17.03 | -0.02 | -0.12% |
ICON Equity Income Investor | |||
FBDIX | 131.11 | -0.24 | -0.18% |
Franklin Biotechnology Discovery A |